Jay D. Kranzler, CEO at CYPRESS BIOSCIENCE INC (CYPB), sold 5,000 shares at $8.08 ($41K) on 2006-11-27, disclosed to the SEC on 2006-11-28.
Scheduled sale ($41k) by CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.05 | 100 | $805 | 2.0% |
| 2 | $8.06 | 300 | $2K | 5.9% |
| 3 | $8.07 | 400 | $3K | 7.9% |
| 4 | $8.08 | 200 | $2K | 4.0% |
| 5 | $8.09 | 200 | $2K | 4.0% |
| 6 | $8.10 | 100 |
| $810 |
| 2.0% |
| 7 | $8.11 | 800 | $6K | 16.0% |
| 8 | $8.12 | 300 | $2K | 6.0% |
| 9 | $8.13 | 300 | $2K | 6.0% |
| 10 | $8.14 | 100 | $814 | 2.0% |
| 11 | $8.15 | 400 | $3K | 8.0% |
| 12 | $8.16 | 900 | $7K | 18.1% |
| 13 | $8.17 | 500 | $4K | 10.0% |
| 14 | $8.20 | 100 | $820 | 2.0% |
| 15 | $8.22 | 100 | $822 | 2.0% |
| 16 | $8.25 | 100 | $825 | 2.0% |
| 17 | $8.27 | 100 | $827 | 2.0% |
| Total | $8.13 avg | 5,000 | $41K | 100% |
| Filing → |
| CYPB | SELL | 2010-12-29 | $162K | — | Filing → |
| CYPB | SELL | 2010-12-29 | $983K | — | Filing → |
| CYPB | SELL | 2009-08-04 | $652K | — | Filing → |